Published in Vaccine Weekly, February 21st, 2001
"Immunization with peptide or recombinant proteins generally fails to elicit cytotoxic T lymphocytes (CTL), which are thought to play a key role in the control of virus-infected cells and tumor growth," said N. Haicheur and colleagues, University of Paris. "In this study we show that the non-toxic B subunit of Shiga toxin fused to a tumor peptide derived from the mouse mastocytoma P815 can induce specific CTL in mice without the use of adjuvant."
Haicheur et al. published their study in the Journal of Immunology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly